Instil Bio, Inc.
TIL
$7.96
-$0.02-0.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.46M | 27.22M | 31.53M | 36.35M | 40.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.50M | 51.96M | 53.87M | 50.12M | 50.85M |
| Operating Income | -43.50M | -51.96M | -53.87M | -50.12M | -50.85M |
| Income Before Tax | -47.38M | -71.37M | -75.08M | -84.51M | -78.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.38 | -71.37 | -75.08 | -84.51 | -78.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.38M | -71.37M | -75.08M | -84.51M | -78.03M |
| EBIT | -43.50M | -51.96M | -53.87M | -50.12M | -50.85M |
| EBITDA | -43.45M | -51.43M | -52.61M | -47.97M | -47.73M |
| EPS Basic | -7.08 | -10.78 | -11.39 | -12.92 | -11.97 |
| Normalized Basic EPS | -3.49 | -4.20 | -4.55 | -4.32 | -4.67 |
| EPS Diluted | -7.08 | -10.78 | -11.39 | -12.92 | -11.97 |
| Normalized Diluted EPS | -3.49 | -4.20 | -4.55 | -4.32 | -4.67 |
| Average Basic Shares Outstanding | 26.92M | 26.67M | 26.41M | 26.16M | 26.07M |
| Average Diluted Shares Outstanding | 26.92M | 26.67M | 26.41M | 26.16M | 26.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |